This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its specific structure, featuring a fluoropyridine moiety, makes it valuable in the development of drugs targeting neurological disorders, particularly those involving the modulation of neurotransmitter systems. It is often employed in the creation of selective inhibitors or agonists that interact with specific receptors in the brain, contributing to the treatment of conditions such as depression, anxiety, or cognitive impairments. Additionally, its chiral nature allows for the production of enantiomerically pure compounds, enhancing the efficacy and reducing the side effects of the resulting drugs. Researchers also explore its potential in designing novel therapeutic agents for other diseases, leveraging its unique chemical properties.